top of page
Helping patients understand KRAS cancer research.
KRAS Cancer News & Updates
Honoring Jerry Cornelius of Canyon Creek. Family Man, Texan, Craftsman
https://www.kraskickers.org/post/honoring-jerry-cornelius-of-canyon-creek-family-man-texan-craftsman
KRAS Cancer Connect
Oct 23, 2025
Val: A Life of Courage, Faith, and Hope
Val’s Advice to Others Facing Lung Cancer
...a quiet but powerful advocate, offering guidance to other people, especially young adults with cancer:
“Don’t freak out when you’re diagnosed. And don’t go straight to Google. Statistics don’t define you
KRAS Cancer Connect
Jul 29, 2025
Why AML Treatments Don’t Always Work—and What This Study Reveals About KRAS, NPM1, and Monocytic Resistance
By KRAS Kickers – Cancer Knowledge + Research + Advocacy = Survivorship 📅 May 2025 | 🧬 Published in Blood Cancer Discovery 🔬...
Terri Conneran KRAS Kickers
May 22, 2025
Rare Pancreas cancer FGFR + KRAS trial - comes to you
Rare Pancreatic cancer trial comes to you! FGFR + KRAS
Terri Conneran KRAS Kickers
May 19, 2025
Lung & Pancreatic cancer Patient Knowledge of Research
KRAS Kickers is a cancer patient-led nonprofit organization that shares Knowledge of publicly available Research to empower patients and caregivers to Advocate for Survivorship.
Our goal to kick cancer's KRAS!
Terri Conneran KRAS Kickers
May 7, 2025
Essential Guide to Cancer Biomarkers For Cancer Patients
Need to know what mutation is driving the cancer bus. It's different than noise from the back of the bus.
Biomarkers testing tells us what to Aim for as the cancer driver, not the background noise. Taking out the cancer driver can make the difference.
Biomarkers provide the insights as to what is driving the cancer.
Terri Conneran KRAS Kickers
Apr 22, 2025
Thank You for Giving Us Hope!
By Shannon Roche The Kickers community shared their appreciation with the researchers behind the scenes making the impossible, possible....
shannon8797
Dec 16, 2022
Getting ahold of KRAS Science: Visiting Kevan Shokat at his UCSF Lab
By the time I met Kevan Shokat, KRAS G12D was already the name of the devil my body was fighting.
Then Kevan did something extraordinary. He made me a three dimensional model of KRAS, had it painted, and sent it to me with a handwritten letter.
How KRAS Became Druggable: Kevan Shokat and the Pocket That Opened a New Era of RAS Drugs
more than 60 additional drugs targeting the RAS family are now in development. What began with a chemical foothold in KRAS G12C has become an expanding field of RAS drug discovery. Why This Matters for People With KRAS Cancer The science also explains why knowing the exact KRAS variant matters.
Where can patients find the NCCN guidelines used to guide cancer treatment?
NCCN Guidelines help clinicians determine what evaluations are appropriate, which treatment options are supported by current evidence, when additional testing may be important, and how care may change as a cancer changes.For patients, NCCN offers a version for patients.
bottom of page